Megan Levings

Dr. Megan Levings is a professor in the Department of Surgery and the School of Biomedical Engineering at the University of British Columbia (UBC). Her lab studies how a special kind of white blood cell, known as a T regulatory cell, could be used as a cellular therapy to prevent harmful immune responses. She leads a vibrant group of trainees and staff who are researching how to use T regulatory cells to replace conventional immunosuppression in transplantation and autoimmunity. She is also the project lead for the Advanced Therapeutics Manufacturing Facility, which is UBC’s new Good Manufacturing Practice facility projected to open in 2028. 
 
Dr. Levings has received numerous awards, including the Canadian Society for Immunology Cinader Award and the YWCA Woman of Distinction, Science, Research & Technology. She is internationally recognized in the field of human immunology and is currently the president of the Federation of Clinical Immunology Societies.